INTRODUCTION AND OBJECTIVES: Human detrusor smooth muscle (DSM) can exhibit low amplitude rhythmic contractions (LARC) which may contribute to overactive bladder (OAB) in some patients. The aim of this study was to develop an objective method to identify LARC during urodynamics (UD), categorize patients with significant LARC, and potentially begin to characterize a LARC-mediated OAB/detrusor overactivity subtype.
INTRODUCTION AND OBJECTIVES: Human detrusor smooth muscle (DSM) can exhibit low amplitude rhythmic contractions (LARC) which may contribute to overactive bladder (OAB) in some patients. The aim of this study was to develop an objective method to identify LARC during urodynamics (UD), categorize patients with significant LARC, and potentially begin to characterize a LARC-mediated OAB/detrusor overactivity subtype.
METHODS: An algorithm was developed to analyze UD filling data in low volume (1st 410 seconds) and high volume (final 410s) regions. Fast Fourier Transform (FFT) analysis identified the frequency (F) in the 1-6 cycle/min range associated with the maximum amplitude of the vesical pressure (P ves ) in each region (Fig 1) . A patient-specific range of interest corresponding to F AE 0.5 cycles/min was determined. P ves and P abd amplitudes were analyzed separately to identify both significant (higher than average) and independent (distinct from P abd ) P ves signals. To be significant, P ves amplitude must be > 1.35 standard deviations (SD) above average P ves amplitude. To be independent, the P abd amplitude must be < 1.35 SD above the average P abd amplitude. SD of 1.35 was chosen using an iterative process in 0.05 SD increments to identify the maximum number of significant and independent signals.
RESULTS: This algorithm was used to retrospectively analyze 43 consecutive UD studies which included 25 (14 neurogenic, 11 idiopathic) with detrusor overactivity (58%). The average age of the entire group was 55AE2 years and included 14 men and 29 women. FFT analysis identified a significant and independent P ves signal in 12/43 patients (28%) of which 8/12 (67%, 5 neurogenic, 3 idiopathic) had detrusor overactivity. The average age of patients with significant and independent signals was 54AE5 years and included 6 men and 6 women.
CONCLUSIONS: Analysis of LARC during UD testing identified a subset of patients with a significant and independent slow wave frequency in P ves . Further refinements of this technique may help identify subsets of individuals with LARC-mediated OAB/detrusor overactivity. 
Source of

INTRODUCTION AND OBJECTIVES:
To evaluate the utility of urodynamic studies, performed before primary midurethral sling placement for stress urinary incontinence, in predicting the need for subsequent sling release for voiding dysfunction.
METHODS: The health records of women managed with primary synthetic midurethral sling placement at Mayo Clinic (Rochester, Minnesota) from January 1, 2002, through December 31, 2012, were reviewed. The primary outcome was surgical sling release for postoperative voiding dysfunction (ie, prolonged retention, elevated postvoid residual volumes with new voiding symptoms, or de novo onset or worsening of overactive bladder symptoms). Logistic regression models were used to evaluate associations between potential clinical risk factors and the primary outcome.
RESULTS: Overall, 1,629 women underwent primary synthetic midurethral sling placement during the study timeframe, including 1,081 patients (66%) who underwent a preoperative multichannel urodynamic evaluation. A sling release for voiding dysfunction was performed for 51 patients (3.1%) at a median of 1.9 months postoperatively (interquartile range, 1.3-9.3 months). Patients undergoing sling release were significantly more likely to have had retropubic sling placement (P¼.003) and concomitant prolapse surgery (P¼.005). On univariate analysis, no urodynamic parameters were associated with the risk of sling release; evaluated parameters included peak flow rate (P¼.20), postvoid residual volume (P¼.37), voiding without detrusor contraction (P¼.96), and detrusor pressure at maximal flow (P¼.23).
CONCLUSIONS: Sling release for voiding dysfunction was rare in our cohort. No urodynamic parameters were associated with the risk of sling release.
Source of Funding: None
MP63-09 PREDICTION OF THE LONG-TERM DURABILITY OF SUBURETHRAL SLING BASED ON POSTOPERATIVE URODYNAMICS
Hsin-Ho Liu*, Taichung, Taiwan; Hann-Chorng Kuo, Hualien, Taiwan INTRODUCTION AND OBJECTIVES: Although a high success rate has been achieved in the early follow-up after suburethral sling for stress urinary incontinence(SUI), there are limited data about long-term effects. The objective of this study is to survey the long-term durability of suburethral sling for SUI and to identify urodynamic changes that are correlated with successful outcomes.
METHODS: Totally 309 women underwent 331 retropubic suburethral slings for SUI between 1989 and 2014 in this survey. Patients received standardized urodynamic testing preoperatively as the baseline and postoperatively within 6 months. Surgical results, demographic characteristics, urodynamic parameters, and postoperative clinical manifestation were retrospectively analyzed.
RESULTS: The median follow-up period was 86.6 months. The overall subjective cure rate was 82.5%. Previous SUI surgery has negative influence on cure rate (P .048). 6.2% de novo urge urinary incontinence (UUI) in the successes, but none in the failure group (P .049). Persistent UUI after sling surgery was noted in 66 (24.2%) in the successes and 40 (69%) in the failures (p<.001). 107 women (39.2%) experienced UUI resolution in the successes, and 10 (17.2%) in the failures (P .001). Among successes, a significant interaction (p<.001) was detected between the baseline and postoperative urodynamic parameters, including Qmax, corrected Qmax, postvoid residual (PVR), voiding volume, voiding efficiency(VE), and bladder outlet obstruction index (BOOI). Significantly increased PdetQmax was also observed after surgery (P .015). A significant interaction (P .034) is detected from the baseline to 6 months between successes and failures for BOOI.
CONCLUSIONS: Suburethral sling has a durable long-term effect in our study. There is a trend suggesting that the decreased Qmax, corrected Qmax and VE are associated with surgical success, while increased Pdet. Qmax, BOOI, and PVR are also associated with success. Slight obstruction makes efficacious sling surgery. The increased outlet resistance is essential for achieving dryness.
Source of Funding: none
MP63-10 DO URODYNAMICS PREDICT URINARY RETENTION AFTER SLING PLACEMENT IN THE COMPLEX PATIENT: VALUE OF REPRODUCING SYMPTOMS OF URODYNAMICS
Alyssa Greiman*, Lauren Rittenberg, Lindsey Cox, Ross Rames, Eric Rovner, Charleston, SC INTRODUCTION AND OBJECTIVES: The risk factors for urinary retention (UR) after sling in women with detrusor underactivity (DU)/Valsalva voiding is not well established. There is limited evidence that increasing outlet resistance in those with poor contractility would be a risk factor for urinary retention (UR). Symptoms of DU are often manifest as hesitancy and straining during the voiding phase and urodynamics (UDS) may overestimate this condition due to a number of factors during UDS including: psychogenic inhibition and pain from urethral catheterization. This study examined UR after sling in patients with or without DU/Valsalva voiding to determine if the reproduction of voiding symptoms on UDS in those with DU is predictive of UR after sling.
METHODS: Following IRB approval, we performed a review of patients undergoing sling looking specifically at the occurrence of short and long term urinary retention. Preoperative incontinence symptom score questionnaire and UDS data were obtained from a prospective UDS database in which patients are directly queried at the time of the UDS study whether the filling/storage, and voiding phases of the study reproduced their usual symptoms. Urinary retention was defined as failed void trial requiring prolonged suprapubic catheter drainage or initiation of intermittent catheterization and was assessed at 1 week, 1 month and 3 months.
RESULTS: Of the 96 women who had a sling procedure, 77 (80%) had preoperative UDS. Of those who had UDS, 27 (43%) had denovo UR at some point post-operatively; 5 at 1 week, 7 at 1 month, and 15 at 3 months or longer. 26/27 (96.3%) patients who had UR had APVS versus MUS sling. As compared to those without DU, patients with DU were more likely to have UR (81% vs 56%, p¼0.025). A positive symptom score of incomplete emptying did not increase risk of UR (p¼0.58). 63/77 (82%) patients had UDS which reproduced their voiding symptoms, 23 (37%) of whom had UR. There was no difference in risk of UR in patients with DU/Valsalva voiding whose UDS reproduced voiding symptoms compared to those with DU/Valsalva voiding whose UDS did not reproduce symptoms (OR 0.98, p¼ 0.98 INTRODUCTION AND OBJECTIVES: Occult stress urinary incontinece (OSUI) is defined as the stress incontinence only observed after the reduction of co-existent prolapse. The objective of this study was to investigate OSUI by physical examination and urodynamic study, comparing both methods.
METHODS: This study enrolled 105 women with pelvic organ prolapse stage III and IV, according to the Pelvic Organ Prolapse Quantificaton (POP-Q) system, evaluated prospectively between January and December 2015. The study was reviewed and approved by the school's Institutional Review Board and all included subjects signed informed consent before participating in the study. A standard history and physical examination was carried out and the investigaton of the OSUI was performed on supine standing and lithotomy position, reducing the prolapse using gauze and a Cheron dressing forceps. During physical examination, the patients were requested to cough and to do valsalva maneuver. Afterwords, they were asked to do the same maneuvers during multichannel urodynamics. Both evaluation were perfomed with 300ml bladder filling. The OSUI was defined when there was urine leakage only after the reduction of the prolapse. RESULTS: The mean patient age was 65.7 years, ranging from 40 to 89 years, mean parity 5.1 and mean body mass index 27.4. From a total of 105 patients, 70 (66.7%) presented with POP-Q stage III and
